【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Overview 11
Therapeutics Development 12
Pipeline Products for Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Overview 12
Pipeline Products for Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Comparative Analysis 13
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Therapeutics under Development by Companies 14
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Therapeutics under Investigation by Universities/Institutes 17
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Unknown Stage Products 21
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Products under Development by Companies 22
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Products under Investigation by Universities/Institutes 25
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Companies Involved in Therapeutics Development 26
AnGes MG, Inc. 26
AstraZeneca PLC 27
Bayer AG 28
Biosidus S.A. 29
Biscayne Pharmaceuticals, Inc. 30
Bristol-Myers Squibb Company 31
Cardiome Pharma Corp 32
CardioVascular BioTherapeutics, Inc. 33
Eagle Pharmaceuticals, Inc. 34
Gilead Sciences, Inc. 35
Hemostemix Ltd 36
Human Stem Cells Institute 37
Isis Pharmaceuticals, Inc. 38
Juventas Therapeutics, Inc. 39
Lacer, S.A. 40
Lee’s Pharmaceutical Holdings Limited 41
Lonestar Heart, Inc. 42
MedImmune, LLC 43
Merck & Co., Inc. 44
Miltenyi Biotec GmbH 45
Multi Gene Vascular Systems Ltd 46
Nuo Therapeutics, Inc. 47
Pluristem Therapeutics Inc. 48
Regado Biosciences, Inc. 49
The Medicines Company 50
ViroMed Co., Ltd. 51
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Therapeutics Assessment 52
Assessment by Monotherapy Products 52
Assessment by Target 53
Assessment by Mechanism of Action 55
Assessment by Route of Administration 57
Assessment by Molecule Type 59
Drug Profiles 61
ACP-01 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
ALD-201 – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
anacetrapib – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
Aptamers for Cardiovascular Diseases – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
BAY-606583 – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
beperminogene perplasmid – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
Biglycan Therapy for Cardiovascular Diseases – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
BIS-5409 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
bivalirudin – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
bivalirudin – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
BQ-123 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
C2 ceramide – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
C6 ceramide – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
cangrelor – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
CAP-1002 – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
Cryocell – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
CVBT-141H – Drug Profile 87
Product Description 87
Mechanism of Action 87
R&D Progress 87
Gemacell – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
Gene Therapy to Activate Vascular Endothelial Growth Factor for Cardiovascular Diseases – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
Gene Therapy to Activate VEGF for Ischemia – Drug Profile 91
Product Description 91
Mechanism of Action 91
R&D Progress 91
ISIS-APOARx – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
ISIS-CRPRx – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
JVS-100 – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
LA-419 – Drug Profile 96
Product Description 96
Mechanism of Action 96
R&D Progress 96
MEDI-6012 – Drug Profile 97
Product Description 97
Mechanism of Action 97
R&D Progress 97
Monoclonal Antibody to Inhibit CD20 for Cardiovascular Disease – Drug Profile 99
Product Description 99
Mechanism of Action 99
R&D Progress 99
MultiGeneGraft – Drug Profile 100
Product Description 100
Mechanism of Action 100
R&D Progress 100
MZ-004 – Drug Profile 101
Product Description 101
Mechanism of Action 101
R&D Progress 101
Oligonucleotides for Ischemic Heart Disease and Duchenne Muscular Dystrophy – Drug Profile 103
Product Description 103
Mechanism of Action 103
R&D Progress 103
Proteins for Ischemic Heart Disease – Drug Profile 104
Product Description 104
Mechanism of Action 104
R&D Progress 104
ranolazine ER – Drug Profile 105
Product Description 105
Mechanism of Action 105
R&D Progress 105
rivaroxaban – Drug Profile 107
Product Description 107
Mechanism of Action 107
R&D Progress 107
Small Molecule for Coronary Artery Disease – Drug Profile 112
Product Description 112
Mechanism of Action 112
R&D Progress 112
Stem Cell Therapy for Cardiovascular Disease – Drug Profile 113
Product Description 113
Mechanism of Action 113
R&D Progress 113
Stem Cell Therapy for Cardiovascular Diseases – Drug Profile 115
Product Description 115
Mechanism of Action 115
R&D Progress 115
Synthetic Peptides to Modulate CD36 Receptor for Ischemic Heart Disease and Macular Degeneration – Drug Profile 117
Product Description 117
Mechanism of Action 117
R&D Progress 117
tirofiban hydrochloride – Drug Profile 119
Product Description 119
Mechanism of Action 119
R&D Progress 119
VM-202 – Drug Profile 121
Product Description 121
Mechanism of Action 121
R&D Progress 121
XL-652 – Drug Profile 123
Product Description 123
Mechanism of Action 123
R&D Progress 123
ZK-001 – Drug Profile 125
Product Description 125
Mechanism of Action 125
R&D Progress 125
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Recent Pipeline Updates 127
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Dormant Projects 155
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Discontinued Products 158
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Product Development Milestones 159
Featured News & Press Releases 159
Nov 14, 2014: The Medicines Company to Present New Data on Investigational Antiplatelet Agent Cangrelor at 2014 AHA Annual Scientific Sessions in Chicago 159
Oct 27, 2014: The Medicines Company Wins Favorable Judgment in Angiomax (Bivalirudin) Patent Litigation 159
Oct 06, 2014: Capricor Announces Plans to Pursue Clinical Program for the Treatment of Duchenne Muscular Dystrophy With Cardiosphere-Derived Cells (CDCs) 160
Sep 02, 2014: Isis Pharmaceuticals Presents Data On ISIS-APO(A)RX At European Society of Cardiology Congress 2014 160
Jul 07, 2014: The Medicines Company Receives Market Authorization Renewal for Angiox (Bivalirudin) from the European Medicines Agency and the European Commission 161
Apr 28, 2014: The Medicines Company Files Petition Against Aurobindo Over Patent Infringement 162
Mar 30, 2014: Analysis of EUROMAX and HORIZONS-AMI Trials of The Medicines Company’s Angiomax Presented at ACC.14 162
Dec 23, 2013: European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company’s Cangrelor 163
Oct 11, 2013: Medicure Announces Approval of Recommended Dosing Regimen for AGGRASTAT 164
Oct 09, 2013: First Patient Enrolled in Phase III Trial Evaluating The Medicines Company’s Angiomax in Patients Undergoing Peripheral Endovascular Procedures 164
Appendix 166
Methodology 166
Coverage 166
Secondary Research 166
Primary Research 166
Expert Panel Validation 166
Contact Us 167
Disclaimer 167
【レポート販売概要】
■ タイトル：冠動脈疾患(CAD)(虚血性心疾患)の治療薬パイプライン動向（2015年上半期版）■ 英文：Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6034IDB
■ 調査対象地域：グローバル
- Pneumonia：医療検査市場2014The report presents a detailed analysis of the Pneumonia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- インテリジェント仮想アシスタント（IVA）の世界市場分析：タイプ別（音声認識、テキスト – 音声認識）、サービス別（カスタマーサービス、マーケットアシスタント）、用途別（BFSI、自動車、IT･テレコム、小売、ヘルスケア、教育）、エンドユーザー別（中小企業、大企業、個人ユーザー）、セグメント予測The global Intelligent Virtual Assistant (IVA) market size is expected to reach USD 12.28 billion by 2024 according to a new report by Grand View Research, Inc. Demand for online self-service and growing need for self-reliance and rapid resolution of queries are expected to be the primary contributors to market growth. Online websites have become the preferred service channel for consumers gatheri …
- 世界の乗用自動車用死角検知(BSD)システム及びアダプティブ・クルーズ・コントロール(ACC)システム市場Active safety systems in passenger cars are becoming more important consideration for consumers and car manufacturers. Active system plays a crucial role in preventing accidents. Active safety system such as Blind Spot Detection (BSD) system and Adaptive Cruise Control (ACC) system respond at different instances to prevent the car from an accident. This technology is majorly installed in premium o …
- 止血装置の世界市場2017-2021ABSTRACTAbout Tourniquets Device A tourniquet is a compressing device used to control or resist blood flow during accidents or surgical procedures. Pressure is applied circumferentially to the skin and the underlying tissues of a limb; this pressure causes a temporary occlusion. Tourniquets are segmented into two types based on product type –– pneumatic and non-pneumatic tourniquets. Pneumatic tou …
- 縫合糸の世界市場：自動縫合器、吸収性縫合糸、非吸収性縫合糸The report on global sutures market analyses and segments the market on the basis of product, application, and region. It analyzes competitive developments, such as alliances, joint ventures, and mergers & acquisitions in the global sutures market. This market is also analyzed with an explicit focus on high-growth applications and fastest-growing market segments. The global sutures market was valu …
- のぼせ症：治療薬のグローバル治験動向（2014年下半期）Hot Flashes Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Hot Flashes Global Clinical Trials Review, H2, 2014" provides data on the Hot Flashes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hot Flashes. It includes an overview of the trial numbers and their recruitment status as per the site of …
- 脊椎用インプラントの世界市場：融合インプラント、非融合インプラントAbout the Spinal Implants Market Spinal implants help correct the deformities of the spine, facilitate bone fusion, and strengthen and stabilize the spine. Conditions such as chronic pain due to degenerative disc diseases (DDDs) and fractures in the spine caused by trauma or osteoporosis can be treated through surgeries that involve the implantation of spinal implants for bone fusion. Spondylolist …
- 世界のデータセンター建設市場動向（2014～2018）TechNavio's analysts forecast the Global Data Center Construction market to grow at a CAGR of 21.99 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing demand for data center colocation services. The Global Data Center Construction market has also been witnessing the adoption of green data center facilities. However, the introduction of conta …
- ガスマスクの世界市場2017-2021About Gas MasksGas masks constitute a prominent category of respiratory protection equipment. Also known as respiratory protection masks, they protect the wearer from toxic agents and pollutants in the environment. Gas masks include products that cover the nose and mouth area or a wider range of facial areas. Leading types of gas masks that are available in the market include self-contained breath …
- 世界のパーキンソン病治療市場（2014-2018）About Parkinson’s Disease Parkinson’s disease is a progressive neurodegenerative disorder characterized by damage of dopaminergic neurons located in various parts of brain including the substantia nigra. This lowers the concentration of dopamine in the striatum. A decrease in dopamine levels by 80 percent leads to the development of symptoms associated with Parkinson’s disease such as tremor, brad …
- 世界の農業用殺虫剤市場（～2019）The global insecticides market is flourishing due to the increasing pressure of meeting the food requirement of the ever-increasing population and the reducing size of arable land. Farmers want to reduce their losses in order to increase crop yield and increase profitability. Insecticides help to kill and inhibit the growth of insects that adversely affect crops, while being totally harmless to no …
- トラクターインプルメントの世界市場予測（～2023年）“The tractor implements market is projected to grow at a CAGR of 5.84% from 2018 to 2023.”The tractor implements market is projected to reach USD 76.1 billion by 2023, from USD 57.3 billion in 2018, at a CAGR of 5.84%. The tractor implements market is driven by various factors such as limited farm labor, government subsidies for usage of farm equipment, and increasing trend of mechanization in agr …
- Oil & Gas Development Company Limited：石油・ガスバリューチェーン分析レポート2013Oil & Gas Development Company Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Oil & Gas Development Company Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Oil & Gas Development Company Limited”. The report provides key information relating to oil and gas assets of the company along with its …
- 世界の拡張現実市場：Global Augmented Reality Market 2014-2018TechNavio's analysts forecast the Global Augmented Reality market to grow at a CAGR of 132.2 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing number of applications. The Global Augmented Reality market has also been witnessing the rapid development of network infrastructure. However, the high cost of augmented reality devices could pose …
- ゴルフカートのアメリカ市場：乗客定員別、種類別、燃料別、用途別、容量別A golf cart is electric powered or gas powered low speed vehicle and it is originally manufactured for the usage in the golf course. Golf cart is very light weight and compact in size. The features such as availability of radio, windshield, rear seat, and others make it popular across various areas including stadiums, golf course, hotels, and others. At present, golf carts are categorized as elect …
